Mathias Weyland

Mr. Mathias Weyland


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2019 in Veterinary and Comparative Oncology
Verified
Journal Article
Closed access
PDF file
LMLaura Marconato
Laura Marconato
MWMathias Weyland
Mathias Weyland
NTNina Tresch
Nina Tresch
FRFederica Rossi
Federica Rossi
VLVito Leone
Vito Leone
CBCarla Rohrer Bley
Carla Rohrer Bley

Verified
Journal Article
Open access
PDF file
NSNadine Schulz
Nadine Schulz
HCHassan Chaachouay
Hassan Chaachouay
KNKatarzyna Nytko-Karouzakis
Katarzyna Nytko-Karouzakis
MWMathias Weyland
Mathias Weyland
MRMalgorzata Roos
Malgorzata Roos
CBCarla Rohrer Bley
Carla Rohrer Bley
Time resolved data of DNA damage and repair after radiotherapy elucidates the relation between damage, repair, and cell survival. While well characterized in vitro, little is known about the time-course of DNA damage response in tumors sampled from individual patients. Kinetics of DNA damage after radiotherapy was assessed in eight dogs using repeated in vivo samples of tumor and co-irradiated normal tissue analyzed with comet assay and phosphorylated H2AX (γH2AX) immunohistochemistry. In vivo results were then compared (in silico) with a dynamic mathematical model for DNA damage formation and repair. Maximum %DNA in tail was observed at 15–60 min after irradiation, with a rapid decrease. Time-courses of γH2AX-foci paralleled these findings with a small time delay and were not influenced by covariates. The evolutionary parameter search based on %DNA in tail revealed a good fit of the DNA repair model to in vivo data for pooled sarcoma time-courses, but fits for individual sarcoma time-courses suffer from the heterogeneous nature of the in vivo data. It was possible to follow dynamics of comet tail intensity and γH2AX-foci during a course of radiation using a minimally invasive approach. DNA repair can be quantitatively investigated as time-courses of individual patients by integrating this resulting data into a dynamic mathematical model.

29 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KNKatarzyna Nytko-Karouzakis
Katarzyna Nytko-Karouzakis
PTPauline Thumser-Henner
Pauline Thumser-Henner
GRGiancarlo Russo
Giancarlo Russo
MWMathias Weyland
Mathias Weyland
CBCarla Rohrer Bley
Carla Rohrer Bley
Pre-treatment of tumors with hyperthermia is often used to increase the efficacy of radiotherapy. One of the main proteins induced in response to hyperthermia is heat shock protein 70 (HSP70). The aim of our study was to investigate up- and down-regulated genes in response to (thermo)radiotherapy in HSP70 proficient and deficient canine osteosarcoma cell line (Abrams), and functional role of HSP70 in the mechanism of thermoradiosensitization. Cells were transfected with negative control siRNA or siRNA targeting HSP70 and treated with hyperthermia (HT), radiotherapy (RT), and thermoradiotherapy (HTRT). RNA sequencing was used to analyze gene expression. Hyperthermia and thermoradiotherapy, but not radiotherapy alone, induced differential gene expression. We identified genes differentially expressed only in HSP70 knockdown (thus HSP70-dependent) cells in response to hyperthermia and thermoradiotherapy. Interestingly, cell proliferation but not clonogenicity and apoptosis/necrosis was affected by the HSP70 knockdown in response to thermoradiotherapy. The results suggest that HSP70 regulates expression of specific genes in response to hyperthermia and thermoradiotherapy. Further investigations into the role of specific genes regulated in a HSP70-dependent manner in response to thermoradiotherapy could pave a way into new, combinatorial treatment options for (canine) osteosarcoma and other cancer types.

21 August 2022 in International Journal of Hyperthermia
Verified
Journal Article
Open access
Oliver RiestererOliver Riesterer
Oliver Riesterer
AAAdela Ademaj
Adela Ademaj
EPEmsad Puric
Emsad Puric
BEBrigitte Eberle
Brigitte Eberle
MBMarcus Beck
Marcus Beck
Pirus GhadjarPirus Ghadjar
Pirus Ghadjar
Transurethral resection of bladder tumor (TUR-BT) followed by chemoradiation (CRT) is a valid treatment option for patients with muscle-invasive bladder cancer (MIBC). This study aimed to investiga...

24 November 2024 in European Journal of Radiology Open
Verified
Journal Article
Open access
MZMichael Zellner
Michael Zellner
STSebastian Tschauner
Sebastian Tschauner
MWMathias Weyland
Mathias Weyland
PHPeter Eggenberger Hotz
Peter Eggenberger Hotz
SSStephan Scheidegger
Stephan Scheidegger
CKChristian J. Kellenberger
Christian J. Kellenberger
To investigate a quantitative method for assessing image quality of low dose lung computed tomography (CT) and find the lowest exposure dose providing diagnostic images. Axial volumetric lung CT acquisitions (256 slice scanner) were performed on three different sized anthropomorphic phantoms at different dose levels. The maximum steepness of sigmoid curves fitted to line density profiles was measured at lung-to-pleura interfaces. For each phantom, image sharpness was calculated as the median of 468 measurements from 39 different locations. Diagnostic image quality for the adult and paediatric phantom was rated by three radiologists using 4-point Likert scales. The image sharpness cut-off for obtaining adequate image quality was determined from qualitative ratings. Adequate diagnostic image quality was reached at a median steepness of 713 HU/mm in the adult phantom with a corresponding CTDIvol of 0.14 mGy and an effective dose of 0.13 mSv at a dose level of 100 kVp and 10 mA. In the paediatric phantom diagnostic image quality was reached at a median steepness of 1139 HU/mm with a corresponding CTDIvol of 0.13 mGy and an effective dose of 0.08 mSv at a dose level of 100 kVp and 10 mA. Determination of image sharpness on line density profiles can be used as quantitative measure for image quality of lung CT. Sufficient-quality lung CT can be achieved at effective radiation doses of 0.13 mSv (adult phantom) and 0.08 mSv (paediatric phantom). These findings suggest that substantial dose reduction is feasible without compromising diagnostic accuracy.

31 August 2023 in Veterinary and Comparative Oncology
Verified
Journal Article
Open access
KNKatarzyna Nytko-Karouzakis
Katarzyna Nytko-Karouzakis
MWMathias Weyland
Mathias Weyland
SDS. Dressel‐Böhm
S. Dressel‐Böhm
SSS. Scheidegger
S. Scheidegger
LSL. Salvermoser
L. Salvermoser
CBCarla Rohrer Bley
Carla Rohrer Bley
Hyperthermia is a form of a cancer treatment which is frequently applied in combination with radiotherapy (RT) to improve therapy responses and radiosensitivity. The mode of action of hyperthermia is multifactorial; the one hand by altering the amount of the blood circulation in the treated tissue, on the other hand by modulating molecular pathways involved in cell survival processes and immunogenic interactions. One of the most dominant proteins induced by hyperthermia is the major stress‐inducible heat shock protein 70 (Hsp70). Hsp70 can be found in the blood either as a free‐protein (free HSP70) derived from necrotic cells, or lipid‐bound (liposomal Hsp70) when it is actively released in extracellular vesicles (EVs) by living cells. The aim of the study was to evaluate the levels of free and liposomal Hsp70 before and after treatment with RT alone or hyperthermia combined with radiotherapy (HTRT) in dogs and cats to evaluate therapy responses. Peripheral blood was collected from feline and canine patients before and at 2, 4, 6 and 24 h after treatment with RT or HTRT. Hsp70 enzyme‐linked immunosorbent assays (ELISAs) were performed to determine the free and liposomal Hsp70 concentrations in the serum. The levels were analysed after the first fraction of radiation to study immediate effects and after all applied fractions to study cumulative effects. The levels of free and liposomal Hsp70 levels in the circulation were not affected by the first singular treatment and cumulative effects of RT in cats however, after finalizing all treatment cycles with HTRT free and liposomal Hsp70 levels significantly increased. In dogs, HTRT, but not treatment with RT alone, significantly affected liposomal Hsp70 levels during the first fraction. Free Hsp70 levels were significantly increased after RT, but not HTRT, during the first fraction in dogs. In dogs, on the other hand, RT alone resulted in a significant increase in liposomal Hsp70, but HTRT did not significantly affect the liposomal Hsp70 when cumulative effects were analysed. Free Hsp70 was significantly induced in dogs after both, RT and HTRT when cumulative effects were analysed. RT and HTRT treatments differentially affect the levels of free and liposomal Hsp70 in dogs and cats. Both forms of Hsp70 could potentially be further investigated as potential liquid biopsy markers to study responses to RT and HTRT treatment in companion animals.